Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array

被引:71
作者
Zhou, XF
Mok, SC
Chen, Z
Li, Y
Wong, DTW [1 ]
机构
[1] Univ Calif Los Angeles, Div Oral Biol & Med, Sch Dent,Mol Biol Inst, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90095 USA
[3] Harvard Univ, Brigham & Womens Hosp, Lab Gynecol Oncol,Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA
关键词
D O I
10.1007/s00439-004-1163-1
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
Like most human cancers, oral squamous cell carcinoma (SCC) is characterized by genetic instabilities. In this study, a single platform (Affymetrix 10K SNP mapping array) was used to generate both loss of heterozygosity (LOH) and DNA copy number abnormality (CNA) read-outs for precise and high-resolution genetic alteration profiles. As a proof of principle, we performed this concordant analysis on a panel of deletion and trisomy cell lines with known chromosomal alterations and the precise LOH and CNA regions were detected as expected. Using a previously described oral SCC progression model system, we identified a set of genomic regions that may be associated with the malignancy progression, including chromosome regions 3pter-3p35.3, 3p14.1-3p13, 11p, 11q14.3-11q22.2, and 11q13.5-11q14.1. These data show that it is feasible to utilize high-density SNP arrays to generate concordant LOH and CNA profiles at high resolution.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 13 条
[1]
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma [J].
Alimov, A ;
Kost-Alimova, M ;
Liu, J ;
Li, CD ;
Bergerheim, U ;
Imreh, S ;
Klein, G ;
Zabarovsky, ER .
ONCOGENE, 2000, 19 (11) :1392-1399
[2]
High-resolution analysis of DNA copy number using oligonucleotide microarrays [J].
Bignell, GR ;
Huang, J ;
Greshock, J ;
Watt, S ;
Butler, A ;
West, S ;
Grigorova, M ;
Jones, KW ;
Wei, W ;
Stratton, MR ;
Futreal, PA ;
Weber, B ;
Shapero, MH ;
Wooster, R .
GENOME RESEARCH, 2004, 14 (02) :287-295
[3]
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1 [J].
Ding, HM ;
Han, CH ;
Gibson-D'Ambrosio, R ;
Steele, VE ;
D'Ambrosio, SM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) :830-836
[4]
Genetic instabilities in human cancers [J].
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 396 (6712) :643-649
[5]
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection [J].
Li, C ;
Wong, WH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :31-36
[6]
Li C., 2003, The Analysis of Gene Expression Data
[7]
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data [J].
Lin, M ;
Wei, LJ ;
Sellers, WR ;
Lieberfarb, M ;
Wong, WH ;
Li, C .
BIOINFORMATICS, 2004, 20 (08) :1233-1240
[8]
NONTUMORIGENIC SQUAMOUS-CELL CARCINOMA LINE CONVERTED TO TUMORIGENICITY WITH METHYL METHANESULFONATE WITHOUT ACTIVATION OF HRAS OR MYC [J].
MILO, GE ;
SHULER, C ;
KURIAN, P ;
FRENCH, BT ;
MANNIX, DG ;
NOYES, I ;
HOLLERING, J ;
SITAL, N ;
SCHULLER, D ;
TREWYN, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1268-1272
[9]
IMMORTALIZATION OF NORMAL HUMAN ORAL KERATINOCYTES WITH TYPE 16 HUMAN PAPILLOMAVIRUS [J].
PARK, NH ;
MIN, BM ;
LI, SL ;
HUANG, MZ ;
CHERICK, HM ;
DONIGER, J .
CARCINOGENESIS, 1991, 12 (09) :1627-1631
[10]
Molecular cytogenetic characterization of cancer cell alterations [J].
Popescu, NC ;
Zimonjic, DB .
CANCER GENETICS AND CYTOGENETICS, 1997, 93 (01) :10-21